AMGN
Amgen Inc
406.00$
+0.0%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 26.2% | 38.0% | 43.0% | 38.6% | 38.9% | 34.3% | 36.4% | 32.8% | 32.2% | 18.1% | 31.8% | 28.0% | 27.3% | |
| 73.8% | 62.0% | 57.0% | 61.4% | 61.1% | 65.7% | 63.6% | 67.2% | 67.8% | 81.9% | 68.2% | 72.0% | 72.7% | |
| 15.6% | 18.7% | 18.0% | 17.3% | 17.1% | 19.0% | 18.2% | 19.0% | 19.9% | 21.7% | 19.9% | 18.6% | 20.0% | |
| 19.6% | 19.9% | 24.3% | 21.3% | 19.1% | 9.8% | 20.7% | 18.4% | 18.0% | 19.7% | 18.6% | 17.4% | 18.4% | |
| 44.6% | 46.5% | 43.7% | 38.7% | 37.0% | 40.3% | 49.1% | 38.3% | 41.3% | 42.1% | 37.2% | 37.1% | 39.5% | |
| 29.3% | 15.5% | 13.3% | 22.8% | 24.1% | 25.4% | 14.5% | 28.8% | 26.4% | 39.8% | 30.9% | 35.0% | 33.2% | |
| 11.0% | 10.0% | 11.1% | 9.6% | 9.1% | 8.2% | 8.9% | 7.7% | 7.2% | 6.6% | 7.6% | 6.7% | 7.0% | |
| 28.2% | 10.4% | -0.9% | 9.5% | 36.5% | 8.6% | 24.2% | 17.1% | 41.0% | 15.3% | 24.2% | 27.5% | 27.0% | |
| 3.1% | 1.0% | 0.6% | 0.6% | 3.2% | 1.7% | 3.0% | 1.5% | 7.4% | 1.8% | 3.1% | 3.9% | 4.0% | |
| 25.1% | 9.4% | -1.5% | 8.9% | 33.3% | 6.9% | 21.2% | 15.6% | 33.7% | 13.5% | 21.1% | 23.6% | 22.9% | |
| 52.2% | 37.2% | 28.9% | 35.8% | 62.0% | 32.2% | 50.1% | 39.5% | 61.9% | 33.3% | 44.8% | 34.2% | 43.3% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.